Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308514388> ?p ?o ?g. }
- W4308514388 endingPage "e070918" @default.
- W4308514388 startingPage "e070918" @default.
- W4308514388 abstract "Abstract Objective To develop and externally validate the STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY)-Falls clinical prediction model to identify the risk of hospital admission or death from a fall in patients with an indication for antihypertensive treatment. Design Retrospective cohort study. Setting Primary care data from electronic health records contained within the UK Clinical Practice Research Datalink (CPRD). Participants Patients aged 40 years or older with at least one blood pressure measurement between 130 mm Hg and 179 mm Hg. Main outcome measure First serious fall, defined as hospital admission or death with a primary diagnosis of a fall within 10 years of the index date (12 months after cohort entry). Model development was conducted using a Fine-Gray approach in data from CPRD GOLD, accounting for the competing risk of death from other causes, with subsequent recalibration at one, five, and 10 years using pseudo values. External validation was conducted using data from CPRD Aurum, with performance assessed through calibration curves and the observed to expected ratio, C statistic, and D statistic, pooled across general practices, and clinical utility using decision curve analysis at thresholds around 10%. Results Analysis included 1 772 600 patients (experiencing 62 691 serious falls) from CPRD GOLD used in model development, and 3 805 366 (experiencing 206 956 serious falls) from CPRD Aurum in the external validation. The final model consisted of 24 predictors, including age, sex, ethnicity, alcohol consumption, living in an area of high social deprivation, a history of falls, multiple sclerosis, and prescriptions of antihypertensives, antidepressants, hypnotics, and anxiolytics. Upon external validation, the recalibrated model showed good discrimination, with pooled C statistics of 0.833 (95% confidence interval 0.831 to 0.835) and 0.843 (0.841 to 0.844) at five and 10 years, respectively. Original model calibration was poor on visual inspection and although this was improved with recalibration, under-prediction of risk remained (observed to expected ratio at 10 years 1.839, 95% confidence interval 1.811 to 1.865). Nevertheless, decision curve analysis suggests potential clinical utility, with net benefit larger than other strategies. Conclusions This prediction model uses commonly recorded clinical characteristics and distinguishes well between patients at high and low risk of falls in the next 1-10 years. Although miscalibration was evident on external validation, the model still had potential clinical utility around risk thresholds of 10% and so could be useful in routine clinical practice to help identify those at high risk of falls who might benefit from closer monitoring or early intervention to prevent future falls. Further studies are needed to explore the appropriate thresholds that maximise the model’s clinical utility and cost effectiveness." @default.
- W4308514388 created "2022-11-12" @default.
- W4308514388 creator A5000532272 @default.
- W4308514388 creator A5003740694 @default.
- W4308514388 creator A5014545124 @default.
- W4308514388 creator A5023825635 @default.
- W4308514388 creator A5033368484 @default.
- W4308514388 creator A5038151603 @default.
- W4308514388 creator A5042461168 @default.
- W4308514388 creator A5049252097 @default.
- W4308514388 creator A5072175850 @default.
- W4308514388 creator A5072817577 @default.
- W4308514388 creator A5086736480 @default.
- W4308514388 creator A5087460590 @default.
- W4308514388 creator A5087892176 @default.
- W4308514388 date "2022-11-08" @default.
- W4308514388 modified "2023-10-14" @default.
- W4308514388 title "Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study" @default.
- W4308514388 cites W1763709863 @default.
- W4308514388 cites W1964778524 @default.
- W4308514388 cites W1977247044 @default.
- W4308514388 cites W1983460994 @default.
- W4308514388 cites W2006940889 @default.
- W4308514388 cites W2048033270 @default.
- W4308514388 cites W2052941532 @default.
- W4308514388 cites W2055838663 @default.
- W4308514388 cites W2105087430 @default.
- W4308514388 cites W2107165713 @default.
- W4308514388 cites W2113676816 @default.
- W4308514388 cites W2118502261 @default.
- W4308514388 cites W2119852447 @default.
- W4308514388 cites W2121647405 @default.
- W4308514388 cites W2131914658 @default.
- W4308514388 cites W2148092884 @default.
- W4308514388 cites W2152933085 @default.
- W4308514388 cites W2161743657 @default.
- W4308514388 cites W2165812031 @default.
- W4308514388 cites W2198866495 @default.
- W4308514388 cites W2226880313 @default.
- W4308514388 cites W2252398104 @default.
- W4308514388 cites W2291720716 @default.
- W4308514388 cites W2468605082 @default.
- W4308514388 cites W2474667434 @default.
- W4308514388 cites W2480792299 @default.
- W4308514388 cites W2494440153 @default.
- W4308514388 cites W2606909288 @default.
- W4308514388 cites W2613198133 @default.
- W4308514388 cites W2618596952 @default.
- W4308514388 cites W2754160328 @default.
- W4308514388 cites W2770837559 @default.
- W4308514388 cites W2772456786 @default.
- W4308514388 cites W2790467552 @default.
- W4308514388 cites W2791024151 @default.
- W4308514388 cites W2792535583 @default.
- W4308514388 cites W2793318154 @default.
- W4308514388 cites W2799981123 @default.
- W4308514388 cites W2811019392 @default.
- W4308514388 cites W2883189216 @default.
- W4308514388 cites W2898559532 @default.
- W4308514388 cites W3028032558 @default.
- W4308514388 cites W3081583946 @default.
- W4308514388 cites W3123674611 @default.
- W4308514388 cites W3127907964 @default.
- W4308514388 cites W3149026346 @default.
- W4308514388 cites W3159174648 @default.
- W4308514388 cites W3186454670 @default.
- W4308514388 cites W3214488275 @default.
- W4308514388 cites W4200283820 @default.
- W4308514388 cites W4233026002 @default.
- W4308514388 cites W4236098165 @default.
- W4308514388 cites W4250958810 @default.
- W4308514388 cites W4319308488 @default.
- W4308514388 doi "https://doi.org/10.1136/bmj-2022-070918" @default.
- W4308514388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36347531" @default.
- W4308514388 hasPublicationYear "2022" @default.
- W4308514388 type Work @default.
- W4308514388 citedByCount "4" @default.
- W4308514388 countsByYear W43085143882023 @default.
- W4308514388 crossrefType "journal-article" @default.
- W4308514388 hasAuthorship W4308514388A5000532272 @default.
- W4308514388 hasAuthorship W4308514388A5003740694 @default.
- W4308514388 hasAuthorship W4308514388A5014545124 @default.
- W4308514388 hasAuthorship W4308514388A5023825635 @default.
- W4308514388 hasAuthorship W4308514388A5033368484 @default.
- W4308514388 hasAuthorship W4308514388A5038151603 @default.
- W4308514388 hasAuthorship W4308514388A5042461168 @default.
- W4308514388 hasAuthorship W4308514388A5049252097 @default.
- W4308514388 hasAuthorship W4308514388A5072175850 @default.
- W4308514388 hasAuthorship W4308514388A5072817577 @default.
- W4308514388 hasAuthorship W4308514388A5086736480 @default.
- W4308514388 hasAuthorship W4308514388A5087460590 @default.
- W4308514388 hasAuthorship W4308514388A5087892176 @default.
- W4308514388 hasBestOaLocation W43085143881 @default.
- W4308514388 hasConcept C105795698 @default.
- W4308514388 hasConcept C126322002 @default.
- W4308514388 hasConcept C167135981 @default.
- W4308514388 hasConcept C194828623 @default.
- W4308514388 hasConcept C201903717 @default.